Conroy JM - Search Results

1

Chromosome breakage hotspots and delineation of the critical region for the 9p-deletion syndrome.

Christ LA, Crowe CA, Micale MA, Conroy JM, Schwartz S. Christ LA, et al. Among authors: conroy jm. Am J Hum Genet. 1999 Nov;65(5):1387-95. doi: 10.1086/302606. Am J Hum Genet. 1999. PMID: 10521304 Free PMC article.

2

Parental origin of De Novo chromosome 9 deletions in del(9p) syndrome.

Micale MA, Haren JM, Conroy JM, Crowe CA, Schwartz S. Micale MA, et al. Among authors: conroy jm. Am J Med Genet. 1995 May 22;57(1):79-81. doi: 10.1002/ajmg.1320570118. Am J Med Genet. 1995. PMID: 7645605

3

Balanced translocation 46,XY,t(2;15)(q37.2;q11.2) associated with atypical Prader-Willi syndrome.

Conroy JM, Grebe TA, Becker LA, Tsuchiya K, Nicholls RD, Buiting K, Horsthemke B, Cassidy SB, Schwartz S. Conroy JM, et al. Am J Hum Genet. 1997 Aug;61(2):388-94. doi: 10.1086/514852. Am J Hum Genet. 1997. PMID: 9311744 Free PMC article.

4

Molecular and cytogenetic analysis of familial Xp deletions.

Wandstrat AE, Conroy JM, Zurcher VL, Pasztor LM, Clark BA, Zackowski JL, Schwartz S. Wandstrat AE, et al. Among authors: conroy jm. Am J Med Genet. 2000 Sep 11;94(2):163-9. doi: 10.1002/1096-8628(20000911)94:2<163::aid-ajmg9>3.0.co;2-u. Am J Med Genet. 2000. PMID: 10982973

5

Cytogenetic and molecular genetic characterization of trisomy 20 mosaicism in fetal blood and tissues.

Micale MA, Wolff DJ, Dickerman LH, Redline R, Conroy JM, Schwartz S. Micale MA, et al. Among authors: conroy jm. Prenat Diagn. 1996 Oct;16(10):893-7. doi: 10.1002/(SICI)1097-0223(199610)16:10<893::AID-PD962>3.0.CO;2-M. Prenat Diagn. 1996. PMID: 8938057

6

Clinical spectrum and molecular diagnosis of Angelman and Prader-Willi syndrome patients with an imprinting mutation.

Saitoh S, Buiting K, Cassidy SB, Conroy JM, Driscoll DJ, Gabriel JM, Gillessen-Kaesbach G, Glenn CC, Greenswag LR, Horsthemke B, Kondo I, Kuwajima K, Niikawa N, Rogan PK, Schwartz S, Seip J, Williams CA, Nicholls RD. Saitoh S, et al. Among authors: conroy jm. Am J Med Genet. 1997 Jan 20;68(2):195-206. Am J Med Genet. 1997. PMID: 9028458

7

A resource to acquire and summarize pharmacogenetics knowledge in the literature.

Rubin DL, Carrillo M, Woon M, Conroy J, Klein TE, Altman RB. Rubin DL, et al. Stud Health Technol Inform. 2004;107(Pt 2):793-7. Stud Health Technol Inform. 2004. PMID: 15360921

8

Immunologic Factors Associated with Differential Response to Neoadjuvant Chemoimmunotherapy in Triple-Negative Breast Cancer.

Seager RJ, Ko H, Pabla S, Senosain MF, Kalinski P, Van Roey E, Gao S, Strickland KC, Previs RA, Nesline MK, Hastings S, Zhang S, Conroy JM, Jensen TJ, Eisenberg M, Caveney B, Severson EA, Ramkissoon S, Gandhi S. Seager RJ, et al. Among authors: conroy jm. J Pers Med. 2024 Apr 30;14(5):481. doi: 10.3390/jpm14050481. J Pers Med. 2024. PMID: 38793063 Free PMC article.

9

Clinical and Biologic Correlates of ADORA2A Transcriptomic Expression in Cancer.

Shreenivas A, Nishizaki D, Lee S, Pabla S, Nesline M, Conroy JM, DePietro P, Kato S, Kurzrock R. Shreenivas A, et al. Among authors: conroy jm. Int J Mol Sci. 2024 Apr 26;25(9):4742. doi: 10.3390/ijms25094742. Int J Mol Sci. 2024. PMID: 38731962 Free PMC article.

10

Transcriptomic analysis of GITR and GITR ligand reveals cancer immune heterogeneity with implications for GITR targeting.

Moussa P, Kurzrock R, Nishizaki D, Miyashita H, Lee S, Nikanjam M, Pabla S, Nesline MK, Ko H, Conroy JM, DePietro P, Sicklick JK, Kato S. Moussa P, et al. Among authors: conroy jm. Am J Cancer Res. 2024 Apr 15;14(4):1634-1648. doi: 10.62347/ECED5481. eCollection 2024. Am J Cancer Res. 2024. PMID: 38726288 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

125 results

Search Page